Question 1

Where is the Symrise AG stock traded?

Accepted Answer

The Symrise AG stock trades under the ticker SY1.XETRA on the XETRA exchange. ISIN: DE000SYM9999.

Question 2

What does Symrise AG do?

Accepted Answer

Symrise AG is a company characterized by the following investment thesis:

Question 3

What are the key metrics for SY1.XETRA?

Accepted Answer

Key metrics for SY1.XETRA include valuation (P/E 52.8, P/S 2.6, P/B 3.4), profitability (profit margin 5.01%, ROE 6.71%), and growth (revenue –, earnings –). Market capitalization is 12.83B EUR. These metrics give an overview of the company's financial performance and valuation.

Question 4

How has Symrise AG's stock price performed?

Accepted Answer

Symrise AG's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.

Question 5

How is SY1.XETRA valued?

Accepted Answer

SY1.XETRA has the following valuation metrics: P/E Ratio: 52.8, P/S Ratio: 2.6, P/B Ratio: 3.4. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

Question 6

Does SY1.XETRA pay dividends?

Accepted Answer

Yes, SY1.XETRA pays dividends with a dividend yield of 1.3%. Dividends can be an important component of the total return on an investment.

Question 7

What are the key risks when investing in SY1.XETRA?

Accepted Answer

Key risks for SY1.XETRA include: Symrise AG supplies flavours, fragrances, cosmetic active ingredients, and functional ingredients to a concentrated market where a handful of large diversified players and numerous regional specialists compete. Its main public competitors are Givaudan, IFF (which includes DSM-Firmenich), Firmenich, and MANE. The company faces three persistent strategic pressures: competitive intensity, raw-material cost volatility, and the regulatory constraints on ingredient use, alongside the execution risk inherent in integrating acquisitions.Larger competitors—Givaudan, IFF/DSM-Firmenich, and MANE—hold advantages in scale, R&D spending, and customer access, creating sustained pressure on pricing and margins.Raw material and commodity price swings—spanning natural extracts, botanical supplies, and petrochemical-based aroma precursors—can compress gross margins and force companies to adjust pricing downstream.Regulatory constraints on fragrance and flavor ingredients—including EU REACH requirements, IFRA guidelines, FDA standards, and comparable jurisdictional rules—can necessitate product reformulations, elevate compliance expenses, or narrow the addressable market for finished goods.Acquisition and integration execution risk can affect earnings, cash flow, and credit metrics through challenges in realizing synergies, managing cultural integration, and handling increased debt [8, 3, 21].Investors should consider these risk factors carefully before making an investment decision.

Question 8

Who are the main competitors of Symrise AG?

Accepted Answer

Symrise AG competes with several listed peers in its sector. Symrise operates across flavors, fragrances, cosmetic active ingredients, and nutrition and health ingredients. Its competitors range from a handful of large global specialty-ingredients companies to numerous regional and private makers. The competitive landscape is shaped by a few large public peers that possess scale, broad R&D capabilities, and established global customer relationships. Raw-material and energy cost volatility present ongoing pressure, as do regulatory and compliance shifts affecting ingredient approvals. The company faces execution risks around acquisitions and integration, while broader market demand cycles and currency movements influence both margins and growth trajectories. Symrise's own disclosures identify climate, supply-chain, regulatory, and IT risks as potential material headwinds to EBIT under adverse scenarios.Givaudan (GIVN.SWX)IFF (International Flavors & Fragrances) (IFF.NYSE)Mane (MAN.PA)These competitors influence pricing power, growth opportunities and relative valuation.

Question 9

When does Symrise AG report earnings?

Accepted Answer

Symrise AG's next earnings report date is March 4, 2027.

Symrise AG Key Metrics

Key Metrics

Valuation Metrics

Profitability Metrics

Growth Metrics

Get More Stock Analyses Like This

Unlock Premium

Full Analysis

Ready for professional stock analysis?

Try for Free

Learn more